Utility of Pancreas Surface Lobularity as a CT Biomarker for Opportunistic Screening of Type 2 Diabetes

Le résumé fourni par la source

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disease that affects millions of people worldwide. Early detection is crucial as it can alter pancreas function through morphological changes and increased deposition of ectopic fat, eventually leading to organ damage. While studies have shown an association between T2DM and pancreas volume and fat content, the role of increased pancreatic surface lobularity (PSL) in patients with T2DM has not been fully investigated. In this pilot work, we propose a fully automated approach to delineate the pancreas and other abdominal structures, derive CT imaging biomarkers, and opportunistically screen for T2DM. Four deep learning-based models were used to segment the pancreas in an internal dataset of 584 patients (297 males, 437 non-diabetic, age:$45 \pm 15$years). PSL was automatically detected and it was higher for diabetic patients ($\mathrm{p}=0.01$) at$4.26 \pm 8.32 ~\text{mm}$compared to$3.19 \pm 3.62$mm for non-diabetic patients. The PancAP model achieved the highest Dice score of$0.79 \pm 0.17$and lowest ASSD error of$1.94 \pm 2.63 ~\text{mm}(\mathrm{p}<0.05)$. For predicting T2DM, a multivariate model trained with CT biomarkers attained 0.90 AUC, 66.7 % sensitivity, and 91.9 % specificity. Our results suggest that PSL is useful for T2DM screening and could potentially help predict the early onset of T2DM.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.